COVID-19 Task Force Co-Chairs dermatologist Dr. Joel Gelfand, Psoriasis & Phototherapy Treatment Center at PENN, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center, return to discuss the new vaccines and their use with psoriatic disease treatments. Disclosures/credit: https://www.eeds.com/em/1920. This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.